Over the past three years, 787 different VC investors have made at least one investment in the global biotech space, according to the PitchBook Platform. The combined value of the 1,165 biotech deals during the timeframe—over $19 billion. The most active firms in the space (listed below) feature significant geographic diversity, with headquarters ranging from California and New York to Switzerland and Denmark. Of all the investors, 191 manage between $100 million and $500 million of assets; another 80 manage between $1 billion and $5 billion.
Top VC investors in biotech over the past three years along with their investment counts: